National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 46099-46100 [2012-18875]

Download as PDF Federal Register / Vol. 77, No. 149 / Thursday, August 2, 2012 / Notices Section RC–30, Delegations of Authority All delegations of authority and redelegations of authority made to HRSA officials that were in effect immediately prior to this reorganization, and that are consistent with this reorganization, shall continue in effect pending further re-delegation. This reorganization is effective upon date of signature. Dated: July 16, 2012. Mary K. Wakefield, Administrator. [FR Doc. 2012–18897 Filed 8–1–12; 8:45 am] address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Dated: July 27, 2012. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2012–18877 Filed 8–1–12; 8:45 am] BILLING CODE 4140–01–P National Institutes of Health Clinical Center; Notice of Meeting mstockstill on DSK4VPTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the NIH Advisory Board for Clinical Research. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in section 552b(c)(9)(B), Title 5 U.S.C., as amended because the premature disclosure of other and the discussions would likely to significantly frustrate implementation of recommendations. Name of Committee: NIH Advisory Board for Clinical Research. Date: October 1, 2012. Open: 10 a.m. to 1:15 p.m. Agenda: Discussion of intramural clinical research operational and funding issues. Place: National Institutes of Health, Building 10, 10 Center Drive, CRC Medical Board Room 4–2551, Bethesda, MD 20892. Closed: 1:15 p.m. to 2 p.m. Agenda: To discuss personnel matters. Place: National Institutes of Health, Building 10, 10 Center Drive, CRC Medical Board Room 4–2551, Bethesda, MD 20892. Contact Person: Maureen E. Gormley, Executive Secretary, Mark O. Hatfield Clinical Research Center, National Institutes of Health, Building 10, Room 6–2551, Bethesda, MD 20892, (301) 496–2897. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, VerDate Mar<15>2010 18:15 Aug 01, 2012 Jkt 226001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel Program Project: Immune Regulation by Cannabinoids. Date: September 5–6, 2012. Time: 7 a.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Scott Jakes, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4198, MSC 7812, Bethesda, MD 20892, 301–495– 1506, jakesse@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) PO 00000 Frm 00084 Fmt 4703 Sfmt 4703 46099 Dated: July 27, 2012. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2012–18876 Filed 8–1–12; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Peer Review Meeting. Date: August 27, 2012. Time: 12 p.m. to 3 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call). Contact Person: Maja Maric, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, DHHS/NIH/NIAID, 6700B Rockledge Drive, Room 3266, Bethesda, MD 20892–7616, 301– 451–2634, maja.maric@nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Clinical Trial Implementation Cooperative Agreement (U01). Date: August 28, 2012. Time: 1 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call). Contact Person: Jay Bruce Sundstrom, Ph.D., Scientific Review Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 6700B Rockledge Drive, MSC–7616, Room 3119, Bethesda, MD 20892–7616, 301–496– 7042, sundstromj@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) E:\FR\FM\02AUN1.SGM 02AUN1 46100 Federal Register / Vol. 77, No. 149 / Thursday, August 2, 2012 / Notices Dated: July 27, 2012. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2012–18875 Filed 8–1–12; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY Office of the Secretary Published Privacy Impact Assessments on the Web Privacy Office, DHS. Notice of publication of Privacy Impact Assessments (PIA). AGENCY: ACTION: The Privacy Office of the Department of Homeland Security (DHS or Department) is making available fifteen new or updated PIAs on various programs and systems in DHS. These assessments were approved and published on the Privacy Office’s Web site between March 1, 2012 and May 31, 2012. DATES: The PIAs will be available on the DHS Web site until October 1, 2012, after which they may be obtained by contacting the DHS Privacy Office (contact information below). FOR FURTHER INFORMATION CONTACT: Mary Ellen Callahan, Chief Privacy Officer, Department of Homeland Security, Washington, DC 20528, or email: pia@hq.dhs.gov. SUPPLEMENTARY INFORMATION: Between March 1, 2012 and May 31, 2012, the Department’s Chief Privacy Officer approved and published fifteen Privacy Impact Assessments (PIAs) on the DHS Privacy Office Web site, www.dhs.gov/ privacy, under the link for ‘‘Privacy Impact Assessments.’’ These PIAs cover fifteen separate DHS programs and systems. Below is a short summary of those programs and systems, indicating the responsible DHS component and the date on which the PIA was approved. Additional information can be found on the Web site or by contacting the Privacy Office. System: DHS/USSS/PIA–009 Field Investigative Reporting System (FIRS). Component: United States Secret Service (USSS). Date of approval: March 7, 2012. The USSS has created the Field Investigative Reporting System (FIRS). The USSS’s Criminal Investigative Division is the business owner of FIRS. FIRS consists of seven applications for the reporting of law enforcement activities that fall within the USSS’s jurisdiction, such as investigating counterfeiting and electronic crimes. mstockstill on DSK4VPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 18:15 Aug 01, 2012 Jkt 226001 The USSS completed this PIA because FIRS is a new system that contains PII about the subjects of criminal investigations. System: DHS/NPPD/PIA–010(a) Federal Protective Service (FPS) Dispatch Incident Records Management System Update. Component: National Protection and Programs Directorate (NPPD). Date of approval: March 13, 2012. The PIA updates the NPPD’s FPS Dispatch and Incident Record Management Systems to add the Field Interview Report (FIR) system to its suite of records management systems and to include administrative changes to the existing PIA. FPS uses the FIR system to collect and analyze information from field interviews, contacts, and stops at protected federal facilities around the country that have been identified as a significant vulnerability. NPPD updated this PIA because this new FIR system provides a new mechanism to collect additional/ new PII about members of the public. System: DHS/MGMT/PIA–006 Email Secure Gateway (EMSG). Component: Directorate for Management. Date of approval: March 22, 2012. The Department manages and operates the EMSG, which is used by all DHS email users. This service was previously managed under the DHS Directory Services Electronic Mail System. EMSG handles email traffic in, out, and between DHS, its components, and the Internet, and provides a directory of users’ official contact information. This PIA was conducted to assess the risk associated with the PII that is received and processed within the EMSG system. This PIA does not cover the PII that may be contained within the body of an email or attachment. System: DHS/FEMA/PIA–021 Advanced Call Center Network (ACCN) Platform. Component: Federal Emergency Management Agency (FEMA). Date of approval: March 4, 2012. FEMA, Office of Response and Recovery, Recovery Directorate, Individual Assistance Division, operates the ACCN Platform. ACCN provides intelligent call routing for FEMA’s National Processing and Service Centers in support of disaster survivors who are applicants for FEMA individual assistance (‘‘individual assistance disaster applicants’’). The purpose of this system is to provide applicants requesting assistance under the Robert T. Stafford Disaster Relief and Emergency Assistance Act, the highest quality of technology and support PO 00000 Frm 00085 Fmt 4703 Sfmt 4703 services. FEMA conducted this PIA because ACCN uses individual assistance disaster applicants’ PII to provide status updates regarding their individual assistance disaster application. System: DHS/FEMA/PIA–022 Student Training/Exercise Application and Registration Records (STARRS). Component: FEMA. Date of approval: March 29, 2011. FEMA collects, uses, maintains, retrieves, and disseminates STARRS of training sponsors, hosts, and attendees and conducts numerous training and exercise programs/systems, including conferences and seminars hosted by FEMA, in support of its mission. These programs collect PII to register individuals for the respective training and exercise programs/systems; coordinate field exercises; and support the general administration of all registration, training, and exercise delivery and course evaluation for FEMA employees, contractors, members of the first responder community, and others. Where possible, FEMA’s training and exercise programs/systems collect non-sensitive PII such as contact information, business card information, biographies, and phone lists; however some programs and systems collect Sensitive PII (SPII) such as Social Security Numbers, performance information, financial information, name plus date of birth, and medical information because of the nature of the training or exercise program. This PIA documents how FEMA collects, uses, maintains, retrieves, and disseminates both PII and SPII in support of its training and exercise missions. System: DHS/USSS/PIA–010 Enterprise Investigative System (EIS). Component: USSS. Date of approval: March 30, 2012. The USSS uses EIS to collect information about ongoing and resolved investigative cases and about individuals seeking access to USSS -protected events. EIS is a compilation of six applications that reside on the USSS mainframe computer system. These applications are used collectively to protect the integrity of the nation’s financial systems and are managed by several entities within the Office of Investigations. This PIA was conducted because EIS collects PII. System: DHS/ICE/PIA–006(b) Data Analysis and Research for Trade Transparency System (DARTTS) Update. Component: Immigration and Customs Enforcement (ICE). Date of approval: April 2, 2012. The original PIA for DARTTS was published in October 2008, and re- E:\FR\FM\02AUN1.SGM 02AUN1

Agencies

[Federal Register Volume 77, Number 149 (Thursday, August 2, 2012)]
[Notices]
[Pages 46099-46100]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-18875]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Peer Review Meeting.
    Date: August 27, 2012.
    Time: 12 p.m. to 3 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6700B Rockledge Drive, 
Bethesda, MD 20817, (Telephone Conference Call).
    Contact Person: Maja Maric, Ph.D., Scientific Review Officer, 
Scientific Review Program, Division of Extramural Activities, DHHS/
NIH/NIAID, 6700B Rockledge Drive, Room 3266, Bethesda, MD 20892-
7616, 301-451-2634, maja.maric@nih.gov.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Clinical Trial Implementation 
Cooperative Agreement (U01).
    Date: August 28, 2012.
    Time: 1 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6700B Rockledge Drive, 
Bethesda, MD 20817, (Telephone Conference Call).
    Contact Person: Jay Bruce Sundstrom, Ph.D., Scientific Review 
Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 6700B 
Rockledge Drive, MSC-7616, Room 3119, Bethesda, MD 20892-7616, 301-
496-7042, sundstromj@niaid.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)


[[Page 46100]]


    Dated: July 27, 2012.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-18875 Filed 8-1-12; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.